No Result
View All Result
Success American Investors
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Success American Investors
No Result
View All Result
Home Editor's Pick

Pig Kidneys to the Rescue?

by
August 17, 2023
in Editor's Pick
0
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Jeffrey Miron

This article appeared on Substack on August 17, 2023.

This past week,

Researchers at the University of Alabama at Birmingham published a peer‐​reviewed study showing that modified pig kidneys performed complex life‐​sustaining functions in a brain‐​dead patient for a full week.

In an apparent response, surgeons at NYU Langone Health announced that a kidney from a genetically modified pig continued to function well after 32 days in a brain‐​dead patient maintained on a ventilator, the longest period for such an experiment.

The patient has shown no signs of rejecting the organ, said Dr. Robert Montgomery, director of the NYU Langone Transplant Institute. But the research has not yet been published in a scientific journal.

This is interesting from a scientific perspective, and perhaps pig kidneys will end up being be more useful than human kidneys, if genetic engineering can reduce their probability of rejection.

Yet such transplants are presumably years away:

So far, transplants of genetically modified pig kidneys have been made only to brain‐​dead patients. Dr. Locke and her colleagues are in discussions with the Food and Drug Administration about launching a first clinical trial in live patients.

Meanwhile,

More than 800,000 American have kidney failure, and over 100,000 are on a waiting list for a transplant. Kidney dialysis can keep patients alive, but the gold standard treatment is an organ transplant.

Yet fewer than 25,000 kidney transplants are performed each year because of a scarcity of human donor organs. Thousands of people on the waiting list die each year.

How can policy address the current shortage? By legalizing organ sales.

Previous Post

Finflow-x Review Explores the Pros and Cons of Brokerage Firm

Next Post

Regulation in the Free Market: It’s Not What Most People Believe

Next Post
Regulation in the Free Market: It’s Not What Most People Believe

Regulation in the Free Market: It’s Not What Most People Believe

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

February 14, 2024

Last Day to Give in 2023!

December 31, 2023
Idaho Bucks Managed Care Trend

Idaho Bucks Managed Care Trend

December 5, 2023

The Producer Price Index

September 9, 2023
Religious Charter Schools? Let States Decide

Religious Charter Schools? Let States Decide

0

0

0

0
Religious Charter Schools? Let States Decide

Religious Charter Schools? Let States Decide

June 2, 2025
How OLN Inc Built a Sales Army One Door at a Time

How OLN Inc Built a Sales Army One Door at a Time

June 2, 2025

Seattle’s Other Monorail: Some Lessons for California

June 2, 2025

AYS Developers Secures Guinness World Record for Largest Real Estate Training in Dubai

June 2, 2025

Recent News

Religious Charter Schools? Let States Decide

Religious Charter Schools? Let States Decide

June 2, 2025
How OLN Inc Built a Sales Army One Door at a Time

How OLN Inc Built a Sales Army One Door at a Time

June 2, 2025

Seattle’s Other Monorail: Some Lessons for California

June 2, 2025

AYS Developers Secures Guinness World Record for Largest Real Estate Training in Dubai

June 2, 2025

Disclaimer: SuccessAmericanInvestors.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.